Julia Dietz

University Hospital Frankfurt

Germany

Research Interests

Explore related searches

Professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (10)

Chaturaka Rodrigo

Senior Lecturer

University of New South Wales

AUSTRALIA

View details

Tanya Applegate

Senior Lecturer

University of New South Wales

AUSTRALIA

View details

Roberto Alonso Fernandez

Instituto de Investigación Sanitaria Gregorio Marañón

SPAIN

View details

Miłosz Parczewski

POLAND

View details

Valeria Ghisetti

Head

ASL Taranto

ITALY

View details

Francesca Ceccherini-Silberstein

University of Rome Tor Vergata

ITALY

View details

Antonio Aguilera

Profesor Titular de Universidad

Universidade de Santiago de Compostela

SPAIN

View details

Valeria Cento

Associate Professor

Humanitas University

ITALY

View details

Andrea De Gottardi

SWITZERLAND

View details

Velia Chiara Di Maio

University of Rome Tor Vergata

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Julia Dietz

Research Interests

Explore related searches

Contact this professor

Articles (10)

Reply to „Real-world effectiveness of voxilaprevir/velpatasvir/sofosbuvir in DAA failure patients: an integrative analysis”

Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients

Long-term persistence of HCV resistance-associated substitutions after DAA treatment failure

Therapeutic preparedness: DAA-resistant HCV variants in vitro and in vivo

Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy

Reply to: “Glecaprevir/pibrentasvir + sofosbuvir + ribavirin offers high cure rate for hepatitis C virus retreatment in real-world settings”

Not uncommon: HBV genotype G co‐infections among healthy European HBV carriers with genotype A and E infection

Treatment outcomes in hepatitis C virus genotype 1a infected patients with and without baseline NS5A resistance‐associated substitutions

Resistance‐associated substitutions in patients with chronic hepatitis C virus genotype 4 infection

Collaborators (10)

Chaturaka Rodrigo

Tanya Applegate

Roberto Alonso Fernandez

Miłosz Parczewski

Valeria Ghisetti

Francesca Ceccherini-Silberstein

Antonio Aguilera

Valeria Cento

Andrea De Gottardi

Velia Chiara Di Maio

Make your next move.